Difficulty: Medium
Average Score: 75%
Practice
Your patient is diagnosed with myasthenia gravis, and she is given a prescription for pyridostigmine. Which of the following best summarizes the drug's mechanism of action?
Correct answer
D
Rationale
The correct answer is D) Inhibits breakdown of acetylcholine, thereby improving activation of skeletal muscle by acetylcholine. Pyridostigmine is an acetylcholinesterase inhibitor, which means it blocks the enzyme responsible for breaking down acetylcholine. In myasthenia gravis, there is a decrease in acetylcholine receptors at the neuromuscular junction, leading to muscle weakness and fatigue. By inhibiting the breakdown of acetylcholine, pyridostigmine increases the levels of acetylcholine available for binding to the remaining receptors, thereby improving muscle contraction.
Option A is incorrect because pyridostigmine does not block muscarinic receptors but rather enhances the actions of acetylcholine at the neuromuscular junction. Option B is incorrect as pyridostigmine does not affect the reuptake of acetylcholine by motor nerves. Option C is incorrect as pyridostigmine does not inhibit skeletal muscle activation at rest; instead, it facilitates muscle activation by increasing acetylcholine levels.
In an educational context, understanding the mechanism of action of drugs used in myasthenia gravis is crucial for healthcare professionals to provide effective care for patients with this condition. Knowing how pyridostigmine works helps clinicians optimize treatment strategies and manage potential side effects associated with acetylcholinesterase inhibitors.
Option A is incorrect because pyridostigmine does not block muscarinic receptors but rather enhances the actions of acetylcholine at the neuromuscular junction. Option B is incorrect as pyridostigmine does not affect the reuptake of acetylcholine by motor nerves. Option C is incorrect as pyridostigmine does not inhibit skeletal muscle activation at rest; instead, it facilitates muscle activation by increasing acetylcholine levels.
In an educational context, understanding the mechanism of action of drugs used in myasthenia gravis is crucial for healthcare professionals to provide effective care for patients with this condition. Knowing how pyridostigmine works helps clinicians optimize treatment strategies and manage potential side effects associated with acetylcholinesterase inhibitors.